AMA

Lyme & Other Tick-Borne Diseases: Research & Clinical Advances 2023

Retrieved on: 
Thursday, October 5, 2023

JACKSON, N.J., Oct. 5, 2023 /PRNewswire/ -- Lyme Disease Association Inc. (LDA) will hold its 22nd annual scientific conference, Lyme & Other Tick-Borne Diseases: Research & Clinical Advances 2023, virtually on October 13-14, 2023.

Key Points: 
  • JACKSON, N.J., Oct. 5, 2023 /PRNewswire/ -- Lyme Disease Association Inc. (LDA) will hold its 22nd annual scientific conference, Lyme & Other Tick-Borne Diseases: Research & Clinical Advances 2023, virtually on October 13-14, 2023.
  • LDA and Columbia Vagelos College of Physicians and Surgeons are joint providers of the CME conference designed for medical & health professionals & researchers but open to the general public.
  • Topics include Lyme & COVID, Cancer Drug May Help Lyme, Psychedelics, Long-Term Lyme Treatments, Lyme Treatment Trials, Pathogens in Post Mortem Tissue, Mast Cell activation, Alpha-gal, Diagnostics, Eye Screening for Lyme, POTS, and Babesia.
  • Columbia University Vagelos College of Physicians and Surgeons designates this live activity for a maximum of 13.25 AMA PRA Category 1 Credits™.

Talkiatry Earns ACCME® Accreditation, Expands Continuing Medical Education Program

Retrieved on: 
Wednesday, October 4, 2023

National in-network psychiatric practice recognized by Accreditation Council for Continuing Medical Education, underscoring its dedication to enhancing professional development for its clinical talent base

Key Points: 
  • National in-network psychiatric practice recognized by Accreditation Council for Continuing Medical Education, underscoring its dedication to enhancing professional development for its clinical talent base
    CME program establishes Talkiatry as an intellectually stimulating place to work for clinicians focused on personal and professional growth, combining the benefits of academic institution and private practice career tracks
    Patients benefit from engaged clinical workforce using most up-to-date medical practices, while working at the top of their license
    NEW YORK, Oct. 4, 2023 /PRNewswire/ -- Talkiatry today announced the Accreditation Council for Continuing Medical Education (ACCME) has awarded MCCD Psychiatry, the medical affiliate of Talkiatry Provisional Accreditation as a provider of continuing medical education (CME).
  • This accreditation assures the medical community and the public that Talkiatry's 300+ staff psychiatrists receive relevant education that's evidence-based, evaluated for effectiveness, and independent of commercial influence.
  • Post-activity evaluations help measure the impact of the programs and serve to continually improve the quality of Talkiatry's CME Program.
  • Many medical boards and specialty organizations require clinicians to earn a certain number of credits to maintain their medical licensure and specialty certifications.

Billionaire & Serial Entrepreneur Mark Cuban Launches the MCC Network Powered by Fireside as the Premier Platform to Win at Business

Retrieved on: 
Wednesday, October 4, 2023

Fireside, the interactive streaming platform co-founded by Falon Fatemi and Mark Cuban, is thrilled to announce that Cuban will be launching " The MCC Network " powered by Fireside to support the next generation of industry pioneers.

Key Points: 
  • Fireside, the interactive streaming platform co-founded by Falon Fatemi and Mark Cuban, is thrilled to announce that Cuban will be launching " The MCC Network " powered by Fireside to support the next generation of industry pioneers.
  • Led by MCC Investors Haywood L. Perry III and Ansley Carlisle, this landmark Network addition will provide the first-ever interactive company-building network for entrepreneurs and industry titans to share advice and win at business together.
  • The MCC Network, which will be free to access, is a commitment to innovation and community-building.
  • Members will have the opportunity to see themselves on screen side-by-side with the Mark Cuban Companies Network and interact directly with speakers.

AMA Announces 2023 Joy in Medicine Recognized Organizations

Retrieved on: 
Tuesday, October 3, 2023

CHICAGO, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The American Medical Association (AMA) today announced 72 health systems, hospitals and medical groups have earned national distinction as 2023 Joy in Medicine™ recognized organization s.

Key Points: 
  • CHICAGO, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The American Medical Association (AMA) today announced 72 health systems, hospitals and medical groups have earned national distinction as 2023 Joy in Medicine™ recognized organization s.
    The prestigious AMA recognition is presented to eligible organizations dedicated to preserving the well-being of physicians through proven efforts to reduce system-level drivers of work-related burnout.
  • “The organizations designated by the AMA’s Joy in Medicine Health System Recognition Program set a national example as leaders in a movement declaring the well-being of physicians an essential element for providing high-quality care,” said AMA President Jesse M. Ehrenfeld, M.D., M.P.H.
  • These 2023 organizations join a strong cohort of currently recognized organizations from the 2022 program.
  • To learn more about the AMA Joy in Medicine Health System Recognition Program , please read Dr. Ehrenfeld’s viewpoint column.

Dignitana Announces Palmetto GBA Approves First Local Coverage Determination for Scalp Cooling Therapy

Retrieved on: 
Tuesday, October 3, 2023

LUND, Sweden, Oct. 3, 2023 /PRNewswire/ -- Dignitana announces that the Palmetto GBA Medicare Administrative Contractor (MAC) has issued a Local Coverage Determination (LCD) to provide coverage guidance for Scalp Cooling for the Prevention of Chemotherapy-Induced Alopecia.

Key Points: 
  • LUND, Sweden, Oct. 3, 2023 /PRNewswire/ -- Dignitana announces that the Palmetto GBA Medicare Administrative Contractor (MAC) has issued a Local Coverage Determination (LCD) to provide coverage guidance for Scalp Cooling for the Prevention of Chemotherapy-Induced Alopecia.
  • This is the first LCD that has been approved for scalp cooling and is a result of a request made to Palmetto GBA in February 2023 by Dignitana and Paxman.
  • In the Billing and Coding Guide: Scalp Cooling for the Prevention of Chemotherapy-Induced Alopecia , Palmetto GBA reaffirms guidance from CMS, "CMS Internet-Only Manual, Pub.
  • This action solidifying localized coverage further advances support for healthcare providers to receive reimbursement from Medicare to administer FDA-cleared scalp cooling therapy, such as The DigniCap Scalp Cooling System.

TYRION Advances Decentralized Advertising with Strategic Move to Coinbase's Base Chain

Retrieved on: 
Monday, October 2, 2023

In an exhilarating development in the world of crypto and blockchain, TYRION the trailblazer in decentralized advertising, announces its strategic move to build its advertising platform on Coinbase's Base Chain .

Key Points: 
  • In an exhilarating development in the world of crypto and blockchain, TYRION the trailblazer in decentralized advertising, announces its strategic move to build its advertising platform on Coinbase's Base Chain .
  • Base Chain, renowned for its robust scalability, security, and efficiency, aligns seamlessly with TYRION’s mission to revolutionize and decentralize the $377 Billion digital advertising landscape.
  • This strategic alignment heralds a new chapter where the synergies between TYRION and Base Chain will drive unprecedented value for users, partners, and stakeholders.
  • The adaptability and resilience of Base Chain complement TYRION’s innovative approach to decentralized advertising, promising a future where digital advertising is not just seen but is also responsive, engaged, and trusted.

Arbitrum Foundation Partners with Fracton Ventures to Enhance Arbitrum Presence in Japan

Retrieved on: 
Friday, September 29, 2023

NEW YORK, Sept. 29, 2023 /PRNewswire/ -- The Arbitrum Foundation today announced a strategic business alliance with Fracton Ventures Co., Ltd. to launch support for Arbitrum scaling solutions in Japan. Through this partnership, Arbitrum Japan will be developed by Fracton Ventures and will promote the growth of blockchain technology within the region by sparking development and consumer interest within the fast-growing Arbitrum ecosystem.

Key Points: 
  • NEW YORK, Sept. 29, 2023 /PRNewswire/ -- The Arbitrum Foundation today announced a strategic business alliance with Fracton Ventures Co., Ltd. to launch support for Arbitrum scaling solutions in Japan.
  • Through this partnership, Arbitrum Japan will be developed by Fracton Ventures and will promote the growth of blockchain technology within the region by sparking development and consumer interest within the fast-growing Arbitrum ecosystem.
  • The Arbitrum Foundation has a mission to help support and grow the Arbitrum network and its community while remaining at the forefront of blockchain adoption.
  • The Arbitrum Foundation and Fracton Ventures will focus on expanding technical educational content and strengthening the developer community.

This Week in Sports News: 9 Stories You Need to See

Retrieved on: 
Friday, September 29, 2023

NEW YORK, Sept. 29, 2023 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists covering the sports industry stay on top of the week's most newsworthy and popular releases, here's a roundup of stories from the week that shouldn't be missed.

Key Points: 
  • With its top-performing Embody Gaming Chair design as the foundation, each limited-edition chair will be adorned with a unique serial number, making it a collector's dream.
  • Six US athletes have qualified to compete against the world's best Teqers at the World Teqball Championships 2023 in Bangkok, Thailand.
  • Subject Matter Experts: Access ProfNet , a database of industry experts to connect with as sources or for quotes in your articles.
  • Related Resources: Read and subscribe to our journalist- and blogger-focused blog, Beyond Bylines , for media news roundups, writing tips, upcoming events, and more.

Avantect Pancreatic Cancer Test Receives CPT Code and Preliminary Payment Determination from the Centers for Medicare and Medicaid Services

Retrieved on: 
Thursday, September 28, 2023

Effective October 1, 2023, the new CPT code, 0410U, establishes a reimbursement pathway for increased patient access and broader test adoption.

Key Points: 
  • Effective October 1, 2023, the new CPT code, 0410U, establishes a reimbursement pathway for increased patient access and broader test adoption.
  • The Avantect test is intended for patients at high risk for pancreatic cancer, such as those recently diagnosed with Type 2 diabetes or with a family history of pancreatic cancer.
  • In addition, the Centers for Medicare and Medicaid Services (CMS) announced that it has proposed preliminary reimbursement rate determinations for new and revised CPT codes issued by the AMA, including 0410U for the Avantect Pancreatic Cancer Detection Test.
  • Its proprietary epigenomic methods use a standard blood draw to identify pancreatic cancer signals at its earliest stages by measuring levels of the 5-hydroxymethylcytosine (5hmC) in cell-free DNA.

Soluna Project Dorothy 1 Reaches Full Capacity of 50 MW, Company hits 2.6 EH/s Hashrate Milestone

Retrieved on: 
Tuesday, September 26, 2023

John Belizaire, CEO of Soluna Holdings, commented, “We’ve had a busy summer ramping Project Dorothy through record high temperatures.

Key Points: 
  • John Belizaire, CEO of Soluna Holdings, commented, “We’ve had a busy summer ramping Project Dorothy through record high temperatures.
  • As we approach the peak wind months and cooler temperatures in Texas, we have achieved a key milestone to complete Project Dorothy 1 and bring it to its 50 MW capacity.
  • We have also made great progress accelerating development at Project Dorothy 2, Project Kati, and working on operational improvements, including significant reductions in SG&A.
  • Curtailment Consumption Ramps – Soluna has now monetized a groundbreaking 1,286 MWh of curtailed (wasted) energy for its Power Partner at Project Dorothy.